简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

HUT,CXAI和BDRX在市场前的输家中

2024-04-02 20:37

  • Losers: Acorda Therapeutics (ACOR-76% as it files for Chapter 11 bankruptcy.
  • Gritstone Bio (GRTS-43% on prices $32.5M equity offering.
  • Verve Therapeutics (VERV-36% after pausing trial enrollments for lead asset.
  • Canoo (GOEV-29% reports mixed Q4 results.
  • PVH Corp (PVH-23% after Q4 earnings release.
  • Avalo Therapeutics (AVTX) -20% appoints Biotech leaders to board of directors.
  • Pioneer Power Solutions (PPSI-19% after Q4 earnings release.
  • Petros Pharmaceuticals (PTPI) -19%.
  • Imuno (IMNN) -13%.
  • CXApp (CXAI) -14%.
  • Terran Orbital Corp (LLAP-12% after Q4 earnings release.
  • Xilio Therapeutics (XLO-12% reports Q4 results.
  • AST SpaceMobile (ASTS-11% after FY earnings release.
  • Humana (HUM) -10%.
  • Biodexa Pharmaceuticals Plc (BDRX) -10%.
  • Hut 8 Corp (HUT) -9%.
  • iBio (IBIO) -9%.
  • Allego NV (ALLG) -9% to postpone fourth quarter and full year 2023 financial results conference call.
  • Ocugen (OCGN) -8% provides business update with certain financials for the year ending 2023.
  • Petco Health and Wellness Co (WOOF-8% after double downgrade from BofA.
  • Griid Infrastructure (OTCPK:GRDI) -7%.
  • Lytus Technologies Holdings PTV Ltd (LYT) -8%.
  • Cipher Mining (CIFR-7% bitcoin production slips 5% M/M in March.
  • Microstrategy (MSTR) -7%.
  • Argo Blockchain Plc (ARBK) -7%.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。